糖尿病的口服治疗 - Suppr

Suppr

超能文献

Oral therapy in diabetes.

作者信息

Bloom A

出版信息

J R Coll Physicians Lond. 1972 Oct;7(1):61-8.

PMID:4627653

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5368809/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a550/5368809/3df3c4554a21/jrcollphyslond90278-0074-a.jpg

相似文献

Oral therapy in diabetes.

J R Coll Physicians Lond. 1972 Oct;7(1):61-8.

Preliminary trial of a powerful new sulphonylurea in maturity-onset diabetes--HB419 (glibenclamide).

S Afr Med J. 1969 Aug 9;43(32):1002-4.

Editorial: Oral therapy in diabetes mellitus.

South Med J. 1974 Jun;67(6):635-8.

HB419 (glibenclamide) in the treatment of diabetes mellitus.

S Afr Med J. 1969 Aug 9;43(32):981-3.

Seminars on diabetes. II. Principles of management.

Can Med Assoc J. 1971 Nov;105(9):972-3 passim.

Oral substitutes for insulin: modern appraisal of their action and indications.

Isr J Med Sci. 1972 Jun;8(6):677-710.

[Oral therapy of diabetes mellitus with sulfonylurea derivatives].

Med Klin. 1970 Jun 12;65(24):1163-6.

The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal.

Diabetes. 1977 Apr;26(4):314-21. doi: 10.2337/diab.26.4.314.

[Diabetes mellitus. XII. Oral diabetes therapy].

Z Arztl Fortbild (Jena). 1971 Feb 1;65(3):125-30.

Oral sulphonylureas in the management of diabetes.

S Afr Med J. 1971 Jan 30;45(5):118-23.

引用本文的文献

Dietary management of maturity-onset diabetes.

Br Med J. 1980 Jun 7;280(6228):1367-9. doi: 10.1136/bmj.280.6228.1367.

West Indian diabetic population of a large inner city diabetic clinic.

Br Med J (Clin Res Ed). 1981 Nov 21;283(6303):1374-5. doi: 10.1136/bmj.283.6303.1374.

Oral hypoglycaemic agents.

Ir J Med Sci. 1973 May;142(3 Suppl):11-7. doi: 10.1007/BF02947552.

Asian patients attending a diabetic clinic.

Br Med J (Clin Res Ed). 1985 Apr 6;290(6474):1051-2. doi: 10.1136/bmj.290.6474.1051.

本文引用的文献

Phenformin as Adjuvant Oral Therapy in Diabetes.

Br Med J. 1961 Jun 24;1(5242):1796-9. doi: 10.1136/bmj.1.5242.1796.

The hypoglycemic action of phenformin. Effect of phenformin on glucose metabolism in peripheral tissues.

Diabetes. 1962 Jul-Aug;11:281-6.

Remission in diabetes.

Br Med J. 1959 Oct 17;2(5154):731-4. doi: 10.1136/bmj.2.5154.731.

Therapy of diabetes mellitus with combinations of drugs given orally.

N Engl J Med. 1958 Dec 18;259(25):1207-10. doi: 10.1056/NEJM195812182592504.

Tolbutamide in diabetes; some clinical and biochemical studies.

Br Med J. 1957 Aug 10;2(5040):327-31. doi: 10.1136/bmj.2.5040.327.

Specific inhibition of gluconeogenesis by biguanides.

Nature. 1967 Jan 14;213(5072):203-4. doi: 10.1038/213203a0.

The place of phenformin in the treatment of diabetes.

Postgrad Med J. 1969 May;45:5-7.

Adverse reactions to oral antidiabetic agents.

Br Med J. 1971 Jul 3;3(5765):29-30. doi: 10.1136/bmj.3.5765.29.

Lactic acidosis occurring during phenformin therapy.

Postgrad Med J. 1972 Jun;48(560):386-7. doi: 10.1136/pgmj.48.560.386.

Assessment of the need for continued oral therapy in diabetics.

Br Med J. 1972 Mar 11;1(5801):649-51. doi: 10.1136/bmj.1.5801.649.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Oral therapy in diabetes.

J R Coll Physicians Lond. 1972 Oct;7(1):61-8.

Preliminary trial of a powerful new sulphonylurea in maturity-onset diabetes--HB419 (glibenclamide).

S Afr Med J. 1969 Aug 9;43(32):1002-4.

Editorial: Oral therapy in diabetes mellitus.

South Med J. 1974 Jun;67(6):635-8.

HB419 (glibenclamide) in the treatment of diabetes mellitus.

S Afr Med J. 1969 Aug 9;43(32):981-3.

Seminars on diabetes. II. Principles of management.

Can Med Assoc J. 1971 Nov;105(9):972-3 passim.

Oral substitutes for insulin: modern appraisal of their action and indications.

Isr J Med Sci. 1972 Jun;8(6):677-710.

[Oral therapy of diabetes mellitus with sulfonylurea derivatives].

Med Klin. 1970 Jun 12;65(24):1163-6.

The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal.

Diabetes. 1977 Apr;26(4):314-21. doi: 10.2337/diab.26.4.314.

[Diabetes mellitus. XII. Oral diabetes therapy].

Z Arztl Fortbild (Jena). 1971 Feb 1;65(3):125-30.

Oral sulphonylureas in the management of diabetes.

S Afr Med J. 1971 Jan 30;45(5):118-23.

引用本文的文献

Dietary management of maturity-onset diabetes.

Br Med J. 1980 Jun 7;280(6228):1367-9. doi: 10.1136/bmj.280.6228.1367.

West Indian diabetic population of a large inner city diabetic clinic.

Br Med J (Clin Res Ed). 1981 Nov 21;283(6303):1374-5. doi: 10.1136/bmj.283.6303.1374.

Oral hypoglycaemic agents.

Ir J Med Sci. 1973 May;142(3 Suppl):11-7. doi: 10.1007/BF02947552.

Asian patients attending a diabetic clinic.

Br Med J (Clin Res Ed). 1985 Apr 6;290(6474):1051-2. doi: 10.1136/bmj.290.6474.1051.

本文引用的文献

Phenformin as Adjuvant Oral Therapy in Diabetes.

Br Med J. 1961 Jun 24;1(5242):1796-9. doi: 10.1136/bmj.1.5242.1796.

The hypoglycemic action of phenformin. Effect of phenformin on glucose metabolism in peripheral tissues.

Diabetes. 1962 Jul-Aug;11:281-6.

Remission in diabetes.

Br Med J. 1959 Oct 17;2(5154):731-4. doi: 10.1136/bmj.2.5154.731.

Therapy of diabetes mellitus with combinations of drugs given orally.

N Engl J Med. 1958 Dec 18;259(25):1207-10. doi: 10.1056/NEJM195812182592504.

Tolbutamide in diabetes; some clinical and biochemical studies.

Br Med J. 1957 Aug 10;2(5040):327-31. doi: 10.1136/bmj.2.5040.327.

Specific inhibition of gluconeogenesis by biguanides.

Nature. 1967 Jan 14;213(5072):203-4. doi: 10.1038/213203a0.

The place of phenformin in the treatment of diabetes.

Postgrad Med J. 1969 May;45:5-7.

Adverse reactions to oral antidiabetic agents.

Br Med J. 1971 Jul 3;3(5765):29-30. doi: 10.1136/bmj.3.5765.29.

Lactic acidosis occurring during phenformin therapy.

Postgrad Med J. 1972 Jun;48(560):386-7. doi: 10.1136/pgmj.48.560.386.

Assessment of the need for continued oral therapy in diabetics.

Br Med J. 1972 Mar 11;1(5801):649-51. doi: 10.1136/bmj.1.5801.649.